FMC Corporation's stock experienced a significant intraday plummet of 14.66% on Thursday, following the release of disappointing quarterly results and major corporate announcements.

The agricultural sciences company reported a fourth-quarter 2025 revenue miss, recording $1.08 billion against estimates of $1.151 billion, alongside a substantial GAAP loss per share. Simultaneously, the company announced its board has authorized the exploration of strategic options, including a potential sale. Furthermore, FMC issued concerning 2026 revenue guidance projecting a 5% decline at the midpoint, with adjusted earnings per share expected to fall 41% from prior expectations.

The company also signaled near-term pressure, projecting first-quarter 2026 adjusted EBITDA to decline 58% year-over-year, citing price headwinds and significant tariff charges. Management attributed ongoing challenges to delayed customer collections in Brazil, the sale of its India business, and increased generic competition.